Open access · CC-BY
via OpenAlex
Atrial fibrillation
Bianca J.J.M. Brundel, Xun Ai, Mellanie True Hills, Myrthe F. Kuipers, Gregory Y.H. Lip, Natasja M.S. de Groot
Nature Reviews Disease Primers · 2022 · ▲ 483 citations
Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia despite substantial efforts to understand the pathophysiology of the condition and develop improved treatments. Identifying the underlying causative mechanisms of AF in individual patients is difficult and the efficacy of current therapies is suboptimal. Consequently, the incidence of AF is steadily rising and there is a pressing need for novel therapies. Research has revealed that defects in specific molecular pathways underlie AF pathogenesis, resulting in electrical conduction disorders that drive AF. The severity of this so-called electropathology correlates with the stage of AF disease progression and determines the response to AF treatment. Therefore, unravelling the molecular mechanisms underlying electropathology is expected to fuel the development of innovative personalized diagnostic tools and mechanism-based therapies. Moreover, the co-creation of AF studies with patients to implement novel diagnostic tools and therapies is a prerequisite for successful personalized AF management. Currently, various treatment modalities targeting AF-related electropathology, including lifestyle changes, pharmaceutical and nutraceutical therapy, substrate-based ablative therapy, and neuromodulation, are available to maintain sinus rhythm and might offer a novel holistic strategy to treat AF. Atrial fibrillation (AF) is the most common cardiac arrhythmia and is increasing in prevalence as populations age. This Primer provides an overview of AF epidemiology, the mechanisms underlying electropathology in AF, and the diagnostic approaches and treatments, and highlights important directions to improve understanding and management of AF in co-creation with patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41572-022-00347-9
- Canonical
- link ↗
- Fetched
- 2026-06-06 MST
Cite this
APA
Brundel, B.J., Ai, X., Hills, M.T., Kuipers, M.F., Lip, G.Y., & Groot, N.M.D. (2022). Atrial fibrillation. <em>Nature Reviews Disease Primers</em>. https://doi.org/10.1038/s41572-022-00347-9
Vancouver
Brundel BJ, Ai X, Hills MT, Kuipers MF, Lip GY, Groot NMD. Atrial fibrillation. Nature Reviews Disease Primers. 2022. doi:10.1038/s41572-022-00347-9.
BibTeX
@article{bianca2022Atrial,
title = {Atrial fibrillation},
author = {Bianca J.J.M. Brundel and Xun Ai and Mellanie True Hills and Myrthe F. Kuipers and Gregory Y.H. Lip and Natasja M.S. de Groot},
journal = {Nature Reviews Disease Primers},
year = {2022},
doi = {10.1038/s41572-022-00347-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Dijklander Ziekenhuis 2021
Open access · US-GOV
The Dutch Multicentre Study Into Opportunistically Screening Geriatric Patients for Atrial Fibrillation Using a PPG Smartphone App; the Dutch-GERAF Study
Prostate Cancer 2016
Open access · CC-BY
Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy
Nutrients 2026
Open access · OA
Molecular Mechanisms and Nutritional Modulation in Sarcopenia: A Narrative Review.
Ageing research reviews 2026
Citation only
Intracranial aneurysms as a manifestation of premature vascular aging: Cellular senescence, inflammaging, and wall degeneration.
British Medical Bulletin 2008
Citation only
Age-related macular degeneration: diagnosis and management
Survey of Ophthalmology 1988
Open access · CC-BY